WYNDHAM HOTELS & RESORTS REPORTS STRONG THIRD QUARTER RESULTS

Wyndham raised its 2026 adjusted EBITDA outlook to $740–$745 million from $735–$745 million and adjusted diluted EPS to $4.84–$4.92 from $4.71–$4.83. Third-quarter revenue rose 7% to $410 million; reported adjusted EBITDA fell 3% to $207 million, while comparable-basis adjusted EBITDA increased 5%, and U.S. RevPAR grew 6%. The company returned $123 million to shareholders in the quarter and approved a $400 million increase in its share-repurchase authorization.

Analysis

The quality of the beat is better than headline GAAP comparisons suggest, but the forward revision is modest: marketing-fund timing distorts quarterly comparability, while the underlying EBITDA outlook implies only incremental improvement. EPS has additional buyback support, so investors should not capitalize the full per-share upgrade as operating acceleration. The stronger U.S. demand backdrop is strategically valuable for a franchise-heavy model, yet the U.S. room base is contracting; international additions are offset by weaker RevPAR in China and elevated room deletions. That makes conversion of the record pipeline—not its size or stated FeePAR premium—the key medium-term test. New construction is especially exposed to financing costs and franchisee returns, and could take years to contribute fees.

Near term, the October 22 call is the catalyst: listen for Q4 U.S. RevPAR, franchisee health, Revo-related fee deferrals, and whether variable-cost timing unwinds. Over 1–3 months, a continued U.S. demand trend could support estimates, but 6–18 month returns depend on pipeline openings and U.S. room stabilization. The contrarian risk is treating reported EPS guidance as a clean demand signal: buybacks help per-share growth, while China weakness and declining U.S. economy rooms challenge the durability of system growth. Leverage near the company’s target midpoint limits, but does not eliminate, flexibility for repurchases if demand weakens.

Key Decisions for Investors

• Consider a measured long WH on post-call weakness rather than chasing the release; the asset-light model and U.S. RevPAR momentum support earnings resilience, but no valuation data here establishes upside at the current price.
• Do not underwrite the pipeline premium as near-term earnings: track rooms opened versus pipeline, U.S. net room additions/deletions, and franchisee financing conditions over the next several quarters.
• Use the call to test whether Q4 domestic RevPAR is tracking the stated assumption and whether Revo fee deferrals or marketing-fund timing create further noise. A material guide reduction or deteriorating franchisee collections would invalidate the constructive thesis.
• Treat the larger repurchase authorization as capacity, not a commitment. If demand weakens while leverage rises above the stated 3–4x target range, buybacks may support EPS less effectively and compete with balance-sheet flexibility.